Biopharmaceutical company
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about Acadia Pharmaceuticals Inc..
The 1 sources with the most insights about Acadia Pharmaceuticals Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Considering a long position; believes Essential Tremor drug is undervalued despite patent cliff risks.
Considering a long position; believes Essential Tremor drug is undervalued despite patent cliff risks.
Other assets that creators frequently mention in the same content as Acadia Pharmaceuticals Inc..
The most active sources covering Acadia Pharmaceuticals Inc. (ACAD) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Acadia Pharmaceuticals Inc. (ACAD) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Acadia Pharmaceuticals Inc. (ACAD) most frequently also discuss BTC, KRNT, CORW, INTC, BBAI. See the "Discussed alongside" section above for full asset pages.